CD1d-mediated antigen presentation to natural killer T (NKT) cells

Crit Rev Immunol. 2003;23(5-6):403-19. doi: 10.1615/critrevimmunol.v23.i56.30.

Abstract

CD1d molecules are lipid antigen-presenting molecules. They are involved in presenting these antigens to a unique subpopulation of T cells called natural killer T (NKT) cells, which have the capacity to produce both T helper (Th) 1 and Th2 cytokines. Thus, it is possible that the antigens presented by CD1d and/or the level at which they are presented could have profound effects on the immunoregulation of autoimmune and infectious diseases, as well as cancer. Because of the ability of CD1d-binding ligands to modulate NKT cell responses, targeting CD1d-mediated antigen presentation as a novel approach for new therapies in these and other diseases holds great promise.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigen Presentation*
  • Antigens, CD1 / chemistry
  • Antigens, CD1 / genetics
  • Antigens, CD1 / metabolism*
  • Antigens, CD1d
  • Autoimmune Diseases / drug therapy
  • Bacterial Infections / immunology
  • Cytokines / biosynthesis
  • Glycolipids / immunology
  • Glycolipids / therapeutic use
  • Humans
  • Infections / drug therapy
  • Killer Cells, Natural / immunology*
  • Mice
  • Models, Immunological
  • Molecular Sequence Data
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • T-Lymphocyte Subsets / immunology*
  • Tyrosine / chemistry
  • Virus Diseases / immunology

Substances

  • Antigens, CD1
  • Antigens, CD1d
  • CD1D protein, human
  • Cytokines
  • Glycolipids
  • Tyrosine